Comparison of healthcare costs among patients with non-valvular atrial fibrillation treated...

The cost implications of dabigatran in patients with myocardial injury after non-cardiac surgery

A Lamy, W Tong, R Mian, J Vincent, W Szczeklik… - American Journal of …, 2022 - Springer
Abstract Background The Management of Myocardial Injury after Non-Cardiac Surgery
(MANAGE) trial demonstrated that dabigatran 110 mg twice daily was more effective than …
被引用次数：3 相关文章 所有 6 个版本